Literature DB >> 11275376

NK-1 receptor gene expression is related to pain in chronic pancreatitis.

Shailesh V Shrikhande1, Helmut Friess, Fabio F di Mola, Adrien Tempia-Caliera, José R Conejo Garcia, Zhaowen Zhu, Arthur Zimmermann, Markus W Büchler.   

Abstract

Recent theories of pathogenesis of pain in chronic pancreatitis (CP) are neuroimmune interactions of intrapancreatic nerves and inflammatory cells and increase in levels of pain neurotransmitters such as substance P (SP). This study analyzed the expression and localization of neurokinin 1 receptor (NK-1R), which binds SP, and its association with pain and inflammation in CP. Pancreatic tissues from 31 patients (22 males, nine females; mean age 45.9+/-9.4 years) with CP were evaluated. Nine normal pancreases (five males, four females; mean age 42.9+/-9.5 years) served as controls. Quantitative PCR was used to determine the NK-1R mRNA expression levels and in situ hybridization and immunohistochemistry were used to localize expression sites of NK-1R mRNA and protein, respectively. We also analyzed whether an association exists between NK-1R mRNA expression and pain and inflammation. In CP samples, in situ hybridization and immunohistochemistry localized NK-1R mRNA expression and protein mainly in the nerves, ganglia, blood vessels, inflammatory cells and occasionally in fibroblasts. In patients with mild to moderate and strong intensity of pain, NK-1R mRNA levels were increased 14- and 30-fold over controls, respectively. There was a significant relationship between NK-1R mRNA levels and intensity of pain (r=0.46, P=0.03), NK-1R mRNA and the frequency of pain (r=0.51, P=0.04), and NK-1 mRNA and duration of pain (r=0.46, P=0.01) in CP patients, but not with the degree of tissue inflammation. NK-1R signaling may be involved in the pain syndrome of CP. The expression of NK-1R in inflammatory cells and blood vessels also points to an interaction of immunoreactive substance P nerves, inflammatory cells and blood vessels, and further supports the existence of a neuroimmune interaction that probably influences the pain syndrome and chronic inflammatory changes so characteristic of CP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275376     DOI: 10.1016/S0304-3959(00)00436-X

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  24 in total

Review 1.  Pathogenesis of pain in chronic pancreatitis: ongoing enigma.

Authors:  Philippus C Bornman; Israel N Marks; Andrew W Girdwood; Pascal O Berberat; Antanas Gulbinas; Markus W Büchler
Journal:  World J Surg       Date:  2003-10-27       Impact factor: 3.352

Review 2.  Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction.

Authors:  P Di Sebastiano; F F di Mola; D E Bockman; H Friess; M W Büchler
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

3.  Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

Authors:  Louis P Vera-Portocarrero; Ying Lu; Karin N Westlund
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

4.  Substance P and calcitonin gene related peptide mediate pain in chronic pancreatitis and their expression is driven by nerve growth factor.

Authors:  LianSheng Liu; Mohan Shenoy; Pankaj Jay Pasricha
Journal:  JOP       Date:  2011-07-08

Review 5.  Unraveling the mystery of pain in chronic pancreatitis.

Authors:  Pankaj Jay Pasricha
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-24       Impact factor: 46.802

6.  The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis.

Authors:  Güralp O Ceyhan; Frank Bergmann; Mustafa Kadihasanoglu; Mert Erkan; Weon Park; Ulf Hinz; Thomas Giese; Michael W Müller; Markus W Büchler; Nathalia A Giese; Helmut Friess
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 7.  Sensory nerves and pancreatitis.

Authors:  Qingfu Li; Jie Peng
Journal:  Gland Surg       Date:  2014-11

8.  Effects of sensory denervation by neonatal capsaicin administration on experimental pancreatitis induced by dibutyltin dichloride.

Authors:  Tsukasa Ikeura; Yosky Kataoka; Taketoshi Wakabayashi; Tetsuji Mori; Yasuharu Takamori; Shoichiroh Takamido; Kazuichi Okazaki; Hisao Yamada
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

9.  Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial.

Authors:  Tilak Upendra Shah; Rodger Liddle; M Stanley Branch; Paul Jowell; Jorge Obando; Martin Poleski
Journal:  JOP       Date:  2012-09-10

10.  A proposal for a new clinical classification of chronic pancreatitis.

Authors:  Markus W Büchler; Marc E Martignoni; Helmut Friess; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2009-12-14       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.